DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisone (Prednisone) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (97)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisone where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 97   Next >>

Possible Prednisone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-21

Patient: male, weighing 42.6 kg (93.8 pounds)

Reactions: Mouth Ulceration, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 2780 mg

Doxorubicin Hydrochloride
    Dosage: 152 mg

Etoposide
    Dosage: 750 mg

Prednisone
    Dosage: 646 mg

Rituximab (Muab C2b8 Anti Cd20)
    Dosage: 810 mg

Vincristine Sulfate
    Dosage: 3.6 mg



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-08-16

Patient: male, weighing 73.5 kg (161.7 pounds)

Reactions: Escherichia Urinary Tract Infection, Febrile Neutropenia, Proteus Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1370 mg

Doxorubicin Hydrochloride
    Dosage: 91 mg

Prednisone
    Dosage: 350 mg

Rituximab (Maab C2b8 Anti Cd20, Chimeric)
    Dosage: 700 mg

Vincristine Sulfate
    Dosage: 2 mg



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient:

Reactions: Hospitalisation, Neuropathy Peripheral, Vomiting, Febrile Neutropenia, Neutropenia, Neutrophil Count Decreased, Lymphoma

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: for 5 days
    Indication: B-Cell Lymphoma

Prednisone
    Dosage: for 5 days
    Indication: Diffuse Large B-Cell Lymphoma

Radiotherapy
    Indication: Diffuse Large B-Cell Lymphoma

Radiotherapy
    Indication: B-Cell Lymphoma

Rituximab
    Indication: B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Neupogen



Possible Prednisone side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-07

Patient:

Reactions: Lung Infection, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: over 30-60 minutes on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Cyclophosphamide
    Dosage: over 30-60 minutes on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Cyclophosphamide
    Dosage: over 30-60 minutes on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Prednisone
    Dosage: 100 mg, qd on days 3-7
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-05

Prednisone
    Dosage: 100 mg, qd on days 3-7
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-12

Prednisone
    Dosage: 100 mg, qd on days 3-7
    Administration route: Oral
    Start date: 2012-07-12
    End date: 2012-07-12

Rituximab
    Dosage: 375 mg/m2, on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Rituximab
    Dosage: 375 mg/m2, on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Rituximab
    Dosage: 375 mg/m2, on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Vincristine Sulfate
    Dosage: 1.4 mg/m2, on day 3
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-08
    End date: 2012-02-08

Vincristine Sulfate
    Dosage: 1.4 mg/m2, on day 3
    Start date: 2012-07-12
    End date: 2012-07-12

Vincristine Sulfate
    Dosage: 1.4 mg/m2, on day 3
    Start date: 2012-03-01
    End date: 2012-03-01

Vorinostat
    Dosage: on day 1-9
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-07

Vorinostat
    Dosage: on day 1-9
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2012-02-06
    End date: 2012-02-14

Vorinostat
    Dosage: on day 1-5
    Administration route: Oral
    Start date: 2012-07-10
    End date: 2012-07-14



Possible Prednisone side effects in 41 year old male

Reported by a physician from Canada on 2012-08-03

Patient: 41 year old male

Reactions: Ecthyma, Diarrhoea, Pseudomonas Infection, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: B-Cell Lymphoma Stage IV

Doxorubicin HCL
    Indication: B-Cell Lymphoma Stage IV

Prednisone
    Indication: B-Cell Lymphoma Stage IV

Rituximab
    Indication: B-Cell Lymphoma Stage IV

Vincristine
    Indication: B-Cell Lymphoma Stage IV

Other drugs received by patient: Epogen; Enoxaparin Sodium; Filgrastim



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-31

Patient:

Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Chemoradiation
    Indication: Hodgkin's Disease

Cyclophosphamide
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Prednisone
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease



Possible Prednisone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Velcade
    End date: 2012-04-10

Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil



Possible Prednisone side effects in

Reported by a health professional (non-physician/pharmacist) from Russian Federation on 2012-07-26

Patient:

Reactions: Vomiting, Acute Leukaemia, Febrile Neutropenia, Treatment Failure, Neutropenia, Toxicity To Various Agents, Neoplasm, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Chemoradiation
    Indication: Hodgkin's Disease

Cyclophosphamide
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: as part of abvd or beacopp
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Prednisone
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vincristine
    Indication: Hodgkin's Disease



Possible Prednisone side effects in 75 year old male

Reported by a physician from United States on 2012-07-25

Patient: 75 year old male, weighing 74.8 kg (164.6 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral

Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-05-08

Docetaxel
    Indication: Prostate Cancer Metastatic
    Start date: 2012-05-01

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-05-01



Possible Prednisone side effects in 75 year old male

Reported by a physician from United States on 2012-07-24

Patient: 75 year old male, weighing 74.8 kg (164.6 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral

Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-05-08

Docetaxel
    Indication: Prostate Cancer Metastatic
    Start date: 2012-05-01

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-05-01



Possible Prednisone side effects in

Reported by a physician from Italy on 2012-07-20

Patient:

Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 100 mg on days 1-5 for chop and r-chop
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: 375 mg/m2 on day 1 for r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
    Indication: Diffuse Large B-Cell Lymphoma

Other drugs received by patient: Neupogen



Possible Prednisone side effects in 32 year old female

Reported by a physician from Belgium on 2012-07-19

Patient: 32 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1215 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-28

Doxorubicin HCL
    Dosage: 81 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-28
    End date: 2011-12-28

Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-29
    End date: 2011-12-29

Prednisone
    Dosage: 500 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-28

Rituximab
    Dosage: 608 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-28
    End date: 2011-12-28

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-12-28
    End date: 2011-12-28



Possible Prednisone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Prednisone side effects in female

Reported by a physician from France on 2012-07-18

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: Pneumonia, General Physical Health Deterioration, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Istodax
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-12

Prednisone
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13



Possible Prednisone side effects in 83 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: 83 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 400 mg/m2, cyclic, on day 1 of each cycle
    Start date: 2010-10-15

Cyclophosphamide
    Dosage: 400 mg/m2, single (cycle 5)
    Start date: 2011-01-13

Doxorubicin HCL
    Dosage: 25 mg/m2, cyclic, on day 1 of each cycle
    Start date: 2010-10-15

Doxorubicin HCL
    Dosage: 25 mg/m2, single (cycle 5)
    Start date: 2011-01-13

Mabthera
    Dosage: 375 mg/m2, single (cycle 5)
    Start date: 2011-01-13

Mabthera
    Dosage: 375 mg/m2, cyclic, one day 1 of each cycle
    Start date: 2010-10-15

Prednisone
    Dosage: 40 mg/m2, cyclic, from day 1 to day 4 of each cycle
    Administration route: Oral
    Start date: 2010-10-15

Prednisone
    Dosage: 40 mg/m2, 1x/day (cycle 5)
    Administration route: Oral
    Start date: 2011-01-13
    End date: 2011-01-17

Vincristine
    Dosage: 1 mg/m2, cyclic, on day 1 of each cycle
    Start date: 2010-10-15

Vincristine
    Dosage: 1 mg/m2, single (cycle 5)
    Start date: 2011-01-13

Other drugs received by patient: Nexium



Possible Prednisone side effects in

Reported by a physician from United States on 2012-07-16

Patient:

Reactions: Fatigue, Febrile Neutropenia, Peripheral Motor Neuropathy, Peripheral Sensory Neuropathy, Arrhythmia, Cerebral Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Mabthera
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



Possible Prednisone side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride



Possible Prednisone side effects in 61 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-13

Patient: 61 year old male

Reactions: Candida Pneumonia, Bronchopneumonia, Febrile Neutropenia, Respiratory Distress, Organising Pneumonia, Respiratory Failure, Interstitial Lung Disease, Pseudomonal Sepsis, Opportunistic Infection, Stenotrophomonas Sepsis, Tracheitis, Septic Shock, Sinusitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-08

Campath
    Dosage: 30 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-23

Cyclophosphamide
    Dosage: 1380 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Cyclophosphamide
    Dosage: 690 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Doxorubicin HCL
    Dosage: 92 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Doxorubicin HCL
    Dosage: 46 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Pegfilgrastim
    Dosage: 6 mg, qd
    Start date: 2010-03-01
    End date: 2010-03-01

Pegfilgrastim
    Dosage: 3 mg, qd
    Indication: T-Cell Lymphoma

Posaconazole
    Indication: Prophylaxis

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2010-02-22
    End date: 2010-02-26

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-11

Vincristine
    Dosage: 2 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Vincristine
    Dosage: 2 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07



Possible Prednisone side effects in

Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13

Patient:

Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Prophylaxis

Prednisone
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma



Possible Prednisone side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-12

Patient: 67 year old male, weighing 78.0 kg (171.6 pounds)

Reactions: Multi-Organ Failure, Spinal Pain, Nausea, Sepsis, Febrile Neutropenia, Dizziness, Hepatitis B, Cough

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: .25 milligram/kilogram
    Indication: Multiple Myeloma
    Start date: 2009-01-29
    End date: 2009-02-02

Prednisone
    Dosage: 2 milligram
    Indication: Multiple Myeloma
    Start date: 2009-01-29
    End date: 2009-02-02

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-29
    End date: 2009-02-10

Other drugs received by patient: Kalium; Metamizol; Levothyroxine Sodium; Lactulose; Tramadol HCL; Nadroparin; Pantoprazole; Tamsulosin HCL; Allopurinol; Aspirin; Amphotericin B; Nadroparin



Possible Prednisone side effects in male

Reported by a consumer/non-health professional from Germany on 2012-07-10

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Candida Pneumonia, Bronchopneumonia, Tachycardia, Atrial Fibrillation, Febrile Neutropenia, General Physical Health Deterioration, Lactic Acidosis, Respiratory Distress, Respiratory Failure, Skin Lesion, Pseudomonal Sepsis, Tracheitis, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-08

Campath
    Dosage: 30 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-23

Cyclophosphamide
    Dosage: 690 mg, once
    Start date: 2010-02-22
    End date: 2010-02-22

Cyclophosphamide
    Dosage: 1380 mg, unk
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-07

Doxorubicin HCL
    Dosage: 92 mg, unk
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-07

Doxorubicin HCL
    Dosage: 46 mg, once
    Start date: 2010-02-22
    End date: 2010-02-22

Pegfilgrastim
    Dosage: 6 mg, once
    Start date: 2010-03-01
    End date: 2010-03-01

Pegfilgrastim
    Dosage: 3 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-11

Prednisone
    Dosage: 100 mg, qdx5
    Administration route: Oral
    Start date: 2010-02-22
    End date: 2010-02-26

Vasopressin
    Dosage: unk
    Indication: Blood Pressure Management

Vincristine
    Dosage: 2 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-22

Vincristine
    Dosage: 2 mg, unk
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-07

Other drugs received by patient: Zienam; Posaconazole; Taranic; Zienam; Taranic; Candiohermal; Candiohermal



Possible Prednisone side effects in 61 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-10

Patient: 61 year old male

Reactions: Respiratory Failure, Bronchopneumonia, Pseudomonal Sepsis, Febrile Neutropenia, Septic Shock, Tracheitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-08

Campath
    Dosage: 30 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-23

Cyclophosphamide
    Dosage: 1380 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Cyclophosphamide
    Dosage: 690 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Doxorubicin HCL
    Dosage: 46 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Doxorubicin HCL
    Dosage: 92 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Pegfilgrastim
    Dosage: 3 mg, qd
    Indication: T-Cell Lymphoma

Pegfilgrastim
    Dosage: 6 mg, qd
    Start date: 2010-03-01
    End date: 2010-03-01

Posaconazole
    Indication: Prophylaxis

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-11

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2010-02-22
    End date: 2010-02-26

Vincristine
    Dosage: 2 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Vincristine
    Dosage: 2 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-07-09

Patient: male

Reactions: Febrile Neutropenia, Proctalgia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg/m2
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-05-18
    End date: 2012-07-01

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-05-18
    End date: 2012-07-01

Mabthera
    Dosage: 375 mg/m2
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-05-18
    End date: 2012-07-01

Prednisone
    Indication: non-Hodgkin's Lymphoma
    End date: 2012-07-01

Vincristine Sulfate
    Dosage: 1.4 mg/m2
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-05-18
    End date: 2012-07-01

Other drugs received by patient: Acetaminophen; Senna-Mint WAF; Pegfilgrastim; Pantoprazole; Acyclovir; Dexamethasone; Fluconazole



Possible Prednisone side effects in 73 year old male

Reported by a physician from Germany on 2012-07-06

Patient: 73 year old male

Reactions: Stenotrophomonas Infection, Febrile Neutropenia, Atrial Fibrillation, Ileus Paralytic, Multi-Organ Failure, Pneumonia Bacterial, Respiratory Failure, Cardiac Failure, Oesophagitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, q2w
    Indication: T-Cell Lymphoma
    Start date: 2009-06-25
    End date: 2009-09-04

Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2009-06-25
    End date: 2009-09-03

Doxorubicin HCL
    Dosage: 100 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2009-06-25
    End date: 2009-09-03

Pegfilgrastim
    Dosage: 6 mg, q2w
    Indication: T-Cell Lymphoma
    Start date: 2009-06-29
    End date: 2009-09-06

Pegfilgrastim
    Indication: Prophylaxis

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2009-06-17
    End date: 2009-09-10

Vincristine
    Dosage: 1 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2009-06-17
    End date: 2009-09-03

Other drugs received by patient: Ciprofloxacin



Possible Prednisone side effects in 73 year old female

Reported by a physician from Netherlands on 2012-07-04

Patient: 73 year old female, weighing 48.0 kg (105.6 pounds)

Reactions: Pneumocystis Jiroveci Pneumonia, Syncope, Febrile Neutropenia, Staphylococcal Bacteraemia, Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1155 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-10

Cyclophosphamide
    Dosage: 1155 mg, unk
    Start date: 2011-07-04

Doxorubicin HCL
    Dosage: 77 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-10

Doxorubicin HCL
    Dosage: 75 mg, unk
    Start date: 2011-07-04

Neupogen
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2007-07-19

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2011-07-04

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-10

Rituximab
    Dosage: 577 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-10

Rituximab
    Dosage: 560 mg, unk
    Start date: 2011-07-04

Vincristine
    Dosage: 2 unk, unk
    Start date: 2011-07-04

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-06-10

Other drugs received by patient: Omeprazole; Perindopril Erbumine



Possible Prednisone side effects in 69 year old male

Reported by a individual with unspecified qualification from Germany on 2012-07-03

Patient: 69 year old male

Reactions: Anaemia, Febrile Neutropenia, Asthenia, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma

Mabthera
    Indication: non-Hodgkin's Lymphoma

Prednisone
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Indication: non-Hodgkin's Lymphoma



Possible Prednisone side effects in male

Reported by a physician from United States on 2012-06-21

Patient: male, weighing 97.5 kg (214.5 pounds)

Reactions: Febrile Neutropenia, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral

Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-01-03
    End date: 2012-03-11

Docetaxel
    Dosage: cycle 4
    Indication: Prostate Cancer Metastatic
    Start date: 2012-02-28

Docetaxel
    Dosage: cycle 1
    Start date: 2011-12-27

Prednisone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2011-12-27



Possible Prednisone side effects in 44 year old male

Reported by a physician from Netherlands on 2012-06-19

Patient: 44 year old male, weighing 95.0 kg (209.0 pounds)

Reactions: Upper Respiratory Tract Infection, Febrile Neutropenia, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1660 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-12-20

Doxorubicin HCL
    Dosage: 110 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-12-20

Neupogen
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-12-21

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2011-12-20

Rituximab
    Dosage: 800 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-12-20

Vincristine Sulfate
    Dosage: 2 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2011-12-20

Other drugs received by patient: Cotrim; Valaciclovir



Possible Prednisone side effects in female

Reported by a physician from United States on 2012-06-05

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: Productive Cough, Febrile Neutropenia, Upper Gastrointestinal Haemorrhage, Tooth Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 2200 mg

Doxorubicin HCL
    Dosage: 120 mg

Etoposide
    Dosage: 588 mg

Prednisone
    Dosage: 1000 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 640 mg

Vincristine Sulfate
    Dosage: 2.72 mg



Possible Prednisone side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: male, weighing 113.0 kg (248.7 pounds)

Reactions: Gastrointestinal Perforation, Febrile Neutropenia, Infectious Peritonitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Docetaxel
    Dosage: 160 milligram
    Indication: Prostate Cancer
    Start date: 2010-05-18

Docetaxel
    Dosage: 160 milligram
    Start date: 2010-07-07
    End date: 2010-07-07

Lenalidomide
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2010-05-18

Lenalidomide
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2010-07-07
    End date: 2010-07-13

Prednisone
    Dosage: 5 milligram
    Indication: Prostate Cancer
    Start date: 2010-05-18

Prednisone
    Dosage: 5 milligram
    Start date: 2010-07-07
    End date: 2010-07-13

Other drugs received by patient: Primaxin; Sodium Chloride; Sodium Chloride; Ketorolac Tromethamine; Hydromorphone HCL; Warfarin Sodium; Aranesp; Potassium Chloride; Piperacillin and Tazobactam; Lantus; Diflucan; Lotrimin; Demadex; Mycostatin; Vancomycin; Vancomycin; Ciprofloxacin HCL; Ciprofloxacin HCL; Famotidine; Lantus; Amlodipine; Atenolol; Aspirin; Humalog; Vancomycin; Acetaminophen; Hydromorphone HCL; Piperacillin and Tazobactam; Lantus; Flomax; Sodium Chloride; Hydrocodone; FAT Emulsion; Imdur; Imdur; Primaxin; Neulasta; Lortab; Furosemide; Lupron; Vancomycin; Pravastatin; Gastrografin; Imipenem and Cilastatin Sodium; Isosorbide Mononitrate; Demadex; Warfarin Sodium; Enoxaparin; Mephyton; Potassium Chloride; Imipenem and Cilastatin Sodium; Docusate Sodium; Adult TPN



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017